Walker, Heather
Khan, Shabana
Padmanabhan, Sandosh
Pell, Jill P.
Lewsey, Jim
Mackay, Daniel
Dundas, Ruth
Friday, Jocelyn M.
Tran, Tran Q. B.
Brown, Denise
Ho, Frederick
Hastie, Claire E.
Fleming, Michael
Geue, Claudia
Stevenson, Alan
Du Toit, Clea
Jani, Bhautesh Dinesh
Gallacher, Katie
Mark, Patrick B.
Sullivan, Michael K.
Funding for this research was provided by:
Wellcome Trust (223499/Z/21/Z)
UKRI Strength in Places Fund (SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1, SIPF00007/1)
Medical Research Council (MC_UU_00022/2, MC_UU_00022/2)
Chief Scientist Office, Scottish Government Health and Social Care Directorate (SPHSU17, SPHSU17)
British Heart Foundation Centre for Research Excellence (RE/18/6/34217)
Article History
Received: 5 August 2024
Accepted: 25 February 2025
First Online: 4 March 2025
Declarations
:
: Not applicable.
: PBM reports lecture honoraria from Astrazeneca, Pharmacomsos, Bayer, Astellas, GSK and Boehringer Ingelheim outside the submitted work. The other authors have no potential conflicts of interest to declare.
: Delegated research ethics approval was granted for linkage to National Health Service (NHS) patient data by the Local Privacy and Advisory Committee at NHS Greater Glasgow and Clyde. Cohorts and de-identified linked data were prepared by the West of Scotland Safe Haven Research Database at NHS Greater Glasgow and Clyde (IRAS Project ID 321198, REC reference 22/WS/1063, West of Scotland REC 4, .).
: The other authors have no potential conflicts of interest to declare.
: For the purpose of open access, the author(s) has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.